Targeting Myeloid-Derived Suppressor Cells Is a Novel Strategy for Anti-Psoriasis Therapy

Figure 1

The accumulation of human MDSCs is remarkably increased in skin lesions of psoriasis patients. Representative flow cytometry panels for quantification of the accumulation of human MDSCs (CD11b⁺ CD33⁺ HLA-DR^-) in skin lesions of patients with psoriasis (PSO, ) and healthy control subjects (Normal, ). Statistical analysis data is shown in (b). , 2-tailed unpaired Student’s -test was used.